Virtual Reality in End Stage Kidney Disease
ConditionEnd Stage Kidney Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorUniversity of Pennsylvania
About this trial
The goal of this clinical trial to compare the social virtual reality and individual virtual reality in patients with end stage kidney disease who are hemodialysis. The main aim is to determine if there are differences in symptoms between the groups. Participants will use virtual reality glasses for 30-45 minutes during dialysis sessions for 4 weeks.
Eligibility criteria
Qualifiers
Diagnosis of end stage kidney disease with hemodialysis 3 times per week for at least 1 month
Disqualifiers
Acutely ill
Active nausea
Epilepsy
Trial design
Treatments tested in this trial
- Social Virtual Reality
- Individual Virtual Reality
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov